Special Issue "Marine Natural Products from Symbiotic Ecosystems"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (20 July 2018) | Viewed by 28647
Interests: microbial ecology and diversity; microbial systematics; biodiscovery; microbial biotechnology applied; environmental and industrial microbiology; marine microbiology; biological control; actinomycetology; bacteriophages
Special Issues, Collections and Topics in MDPI journals
Special Issue in Diversity: Genetic and Functional Diversity of Microorganisms
Special Issue in Diversity: Diversity of Marine Invertebrate and Seaweed Symbiotic Bacteria
Special Issue in Marine Drugs: Marine Natural Products and Their Translational Applications in Medicine
Special Issue in Antibiotics: Antimicrobial Alternatives against Antimicrobial-Resistant Pathogens
Special Issue in Marine Drugs: Application of Bacteriophages in Marine Environments
Special Issue in Diversity: Diversity and Ecological Roles of Actinomycetes
Special Issue in Pathogens: Ecology and Pathogenicity of Nocardiae
Special Issue in Diversity: Women’s Special Issue Series: Diversity
Special Issue in Diversity: Feature Papers in Microbial Diversity and Culture Collections
Special Issue in Marine Drugs: Marine Bacteriophages and Their Applications
Special Issue in Marine Drugs: Commemorating the Launch of the Section “Marine Biotechnology Related to Drug Discovery or Production”
Marine-derived bioactive compounds have been reported to have functional roles within their symbiotic environments and can chemically range from antimicrobials, pigments, vitamins and enzymes. These compounds can exhibit antibacterial, antiviral, antifungal, antimicrobial or cytotoxic properties. They can also be produced as defense compounds against competitors of their hosts, predators and pathogens thus providing the host with competitive advantages in the environment by increasing their access to space and nutrients through elimination of the competitors. As a result, most symbionts are believed to produce unique compounds for their hosts, and such potent compounds might also have further use in industry. Accordingly, in this Special Issue, the author would like to invite manuscripts specialized in discovery of medicinal and biotechnologically important compounds deriving from symbiosis between marine macro-organisms and microorganisms.
Dr. Ipek Kurtboke
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine microorganisms
- marine symbiosis
- marine biodiscovery
- marine biotechnology
- marine environments